Evren ÖZDEMİR, MD

Medical School

Hacettepe University Faculty of Medicine (English Program)Hacettepe, Ankara, Turkey (1985-1992)

Post-Graduate Training

1992-1997    Research Assistant in Internal Medicine Ege University    Faculty of Medicine Department of Internal Medicine Bornova, Izmir, Turkey

1997-2000 Clinical Fellowship in Hematology-Oncology University of Cincinnati College of Medicine Department of Internal Medicine Division of Hematology-Oncology 231 Bethesda Avenue Cincinnati, OH, USA 45267-0562

2000-2002 Clinical Fellowship in Bone Marrow Transplantation The University of Texas MD Anderson Cancer Center Department of Blood and Marrow Transplantation 1515 Holcombe Blvd. Box: 423 Houston, TX, USA 77030-4009

Professional Experience:

1992-1997 Research Assistant in Internal Medicine Ege University Medical School Hospital Department of Internal Medicine Bornova, Izmir, Turkey

1997-2000 Hematology-Oncology Clinical Fellowship University of Cincinnati College of Medicine Department of Internal Medicine Division of Hematology-Oncology 231 Bethesda Avenue Cincinnati, OH, USA 45267-0562

2000-2002 Bone Marrow Transplantation Clinical Fellowship The     University of Texas MD Anderson Cancer Center Department of Blood and Marrow Transplantation 1515 Holcombe Blvd. Box: 423 Houston, TX, USA 77030-4009

2000-2016    Faculty Member Hacettepe University Cancer Institute  Department of Medical Oncology Hacettepe University Medical School Department of Internal Medicine Division of Medical Oncology Responsible Faculty Member of Adult Oncology, Bone Marrow Transplantation, and Apheresis Units Hacettepe, Ankara 06100

Diplomas and Certificates:

Doctor of Medicine Degree
Ministry of Health, Republic of Turkey, Diploma No: 92092085, 1992

United States Medical Licensing Examination (USMLE) Certificate of Achievement
and Educational Commission for Foreign Medical Graduates (ECFMG) Certificate of Achievement for Foreign Medical Graduates, 1996

Certificate of Specialization in Internal Medicine
Ministry of Health, Republic of Turkey, Registration No: 42404-64919, 1997

Radiation Safety Certificate, University of Cincinnati Radiation Safety
Department, Cincinnati, OH, USA, 1998

Advanced Cardiovascular Life Support (ACLS) Certification, American Heart
Association, 2000

Certificate of Specialization in Hematology-Oncology, University of Cincinnati
College of Medicine, Cincinnati, OH, USA, 2000

Certificate of Specialization in Stem Cell Transplantation, The University of Texas,
MD Anderson Cancer Center, Houston, TX, USA, 2002

Certificate of Specialization in Medical Oncology
Ministry of Health, Republic of Turkey, Registration No: 58837-64919, 2003

Certificate of Specialization in Hematology.
T.C. Sağlık Bakanlığı, Registration No: 58838-64919, 2003

JACIE Inspector, Bone Marrow Transplantation, Apheresis and Cryopreservation Units Inspector, Joint Accreditation Committee ISCT & EBMT (JACIE), 2005

Medical Oncology Qualification Certificate, Turkish Society of Medical Oncology, 2006

Associate Professorship Certificate, 2006

Hacettepe University Faculty of Medicine Dean's Office Research Support Unit Clinical Research and Good Medical Practices Course Certificate, 2007

T.C. Ministry of Health Hacettepe University Faculty of Medicine Adult Oncology Bone Marrow Transplantation Center Responsible Physician Certificate, 2008

Professorship Certificate, 2012

European Hematology Association (EHA) Continuous Medical Education (CME) Achievement Certificate (Platinum Level), 2012

T.C. Ministry of Health Therapeutic Apheresis Responsible Physician Certificate, 2012

Basic Occupational Health and Safety Training Certificate for Hacettepe University Administrators, 2013

Hacettepe University Hospital Management Certificate, 2014

Society of Hematologic Oncology Turkey Representation Certificate, 2015

European Board for Accreditation in Hematology (EBAH) Current Continuous Medical Education (CME) Certificate, 2016.

Professional Association Memberships:

American Society of Blood and Marrow Transplantation (ASBMT)
Society of Hematologic Oncology (SOHO), SOHO Turkey Ambassador
American Society of Hematology (ASH)
American Society of Clinical Oncology (ASCO)
European Society of Oncology (ESMO)
Turkish Society of Hematology (THD)
Turkish Society of Medical Oncology (TTOD)
Turkish Oncology Group Association (TOGD)

Scientific Publication Review Board:

Oncotarget
Clinical Lymphoma, Myeloma & Leukemia
Leukemia & Lymphoma
International Journal of Hematology and Oncology
Turkish Journal of Hematology
Turkish Journal of Cancer

Academic National and International Conferences:

A Case with Lumbar Osteosarcoma. Medical Oncology Fellows ASCO Review Course, hosted by University of Southern California, Los Angeles, CA, May 1998

Identification of A New Hyaluronic Acid Receptor. Hematology-Oncology Grand Rounds, University of Cincinnati, Cincinnati, OH, April 1999

Bronchioloalveolar Carcinoma. Pediatric Hematology-Oncology Grand Rounds, University of Cincinnati Children's Hospital, Cincinnati, OH, March 2000

Management of Chronic Lymphocytic Leukemia. Hematology-Oncology Grand Rounds, University of Cincinnati, Cincinnati, OH, April 2000

Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with impaired cytomegalovirus-specific CD8+ T cell function. 8th International Meeting of the International Society for Cellular Therapy, Barcelona, Spain, May, 2002

Hematopoietic stem cell transplantation in first remission in aggressive non-Hodgkin lymphoma. Turkish Oncology Group Annual Meeting, High Dose Chemotherapy Working Group, Ankara, December 2003

Non-myeloablative allogeneic stem cell transplantation: Experience of Hacettepe University Oncology Institute. 31st Turkish Society of Hematology Congress, Antalya, September 2004

Late complications of hematopoietic stem cell transplantation. Turkish Oncology Group Annual Meeting, High Dose Chemotherapy Working Group, Ankara, June 2005

Non-myeloablative allogeneic stem cell transplantation. Hacettepe Oncology Symposium, Ankara, November 2005
Non-myeloablative stem cell transplantation in solid tumors. National Cancer Week, Ankara, April 2006

Patient selection for 90Y ibritumomab tiuxetan therapy. 7th International Congress of Nuclear Oncology and 18th National Congress of the Turkish Society of Nuclear Medicine, Antalya, Turkey, May 2006

Current Approach in Acute Myeloid Leukemia. Hacettepe Oncology Symposium, Ankara, November 2006

Febrile Neutropenia and Stem Cell Transplantation. 4. Febrile Neutropenia Training Course, Ankara, February 2007

Legal and Ethical Issues in Stem Cell Research, European Union Perspective. 4th National Bone Marrow Transplantation and Cellular Therapy Congress, Bursa, March 2007

Current Treatment of Multiple Myeloma: High-Dose Chemotherapy and Autologous Stem Cell Transplantation. 17. National Cancer Congress, Antalya, April 2007

Current and future regulatory environment for transplant teams. JACIE Course. 33rd National Hematology Congress, Ankara, October 2007

Shall we destroy the bone marrow? Or should we do it downgraded? Allogeneic stem cell transplantation with myeloablative (MA) priming regimens versus non-myeloablative (NMA) priming regimens. 5th National Bone Marrow Transplantation and Cellular Therapy Congress, Antalya, March 2008

Hematopoietic Stem Cell Transplant Applications. Hacettepe University Faculty of Medicine, Department of Internal Medicine, XIII. Postgraduate Training Course, Ankara, March 2008

Role of stem cell transplantation in hematology and oncology. Hacettepe Oncology Symposium, Ankara, November 2008

multiple myeloma. ESMO Course-Essentials of Medical Oncology. Istanbul, Turkey, November 2008

Hematopoietic Stem Cell Transplantation. 4th National Cancer Patients Congress, Ankara, April 2009

Toxicity and Supportive Therapy in Hematopoietic Stem Cell Transplantation. Hematopoietic Stem Cell Transplant Course, Turkish Hematology School, Mardin, June 2009

Donor Lymphocyte Infusion. 4th National Apheresis Congress, TRNC, September 2009

Safe Life After Hematopoietic Stem Cell Transplantation. 9. Febrile Neutropenia Symposium, Ankara, February 2010

Late Complications of Hematopoietic Stem Cell Transplantation. 6th National Bone Marrow Transplantation and Cellular Therapy Congress, Antalya, March 2010

High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma. 3. Medical Oncology Congress, Antalya, March 2010

Hematopoietic Stem Cell Transplantation: Ask Your Specialist. 5th National Cancer Patients Congress, Ankara, April 2010

Management of Lymphoma: Clinical Presentation; Role of PET-CT with Clinical Scenarios; Medical Therapy. 9th International Congress of Nuclear Oncology and 21st National Congress of the Turkish Society of Nuclear Medicine, Antalya, Turkey, April 2010

Microenvironment Changes in Cancer. Target Cancer 2010 Symposium, TRNC, May 2010

Allogeneic Stem Cell Transplantation in Multiple Myeloma. 1st National Lymphoma and Myeloma Congress, Antalya, May 2010

Reduced intensity allogeneic stem cell transplantation in the treatment of older AML patients. 5th Balkan Day of Haematology and 21st Congress of the Hellenic Society of Haematology. Thessaloniki, Greece, November 2010

Non-myeloablative allogeneic stem cell transplantation in Hematology and Oncology. Hacettepe Oncology Symposium, Ankara, November 2010

Advances in Cancer Treatment: Chemotherapy. 6th National Cancer Patients Congress, Ankara, April 2011
Non-myeloablative allogeneic stem cell transplantation in Hematology and Oncology. 19th National Cancer Congress, Antalya, April 2011

Autologous stem cell transplantation and complications, a practical approach. Eurasia Stem Cell Transplantation and Apheresis Symposium, Antalya, Turkey, May 2011

Lymphomas and High Dose Therapy: Very Aggressive Lymphomas. 5. Training Course, Medical Oncology Association, Ankara, June 2011

Stem Cell Transplantation in Hematology and Oncology. Near East University, TRNC, September 2011

Granulocyte Transfusions. 6th National Apheresis Congress, TRNC, September 2011

Management of gastrointestinal lymphomas. 1st International Gastrointestinal Cancer Conference, Antalya, Turkey, November 2011

Stem Cell Transplantation in Hematology and Oncology: Treatment and Complications. 2nd National Healthy Living Symposium, Ankara, February 2012

Approach to Gastrointestinal Lymphomas. 4th Medical Oncology Congress, Antalya, March 2012

Hematological Malignancies and Stem Cell Transplantation: Ask Your Specialist. 7th National Cancer Patients Congress, Ankara, April 2012

Hematopoietic Stem Cell Transplantation in Rheumatological Diseases: Stem Cell Transplantation Techniques and Problems. 7th Anatolian Rheumatology Days, Nevşehir, May 2012

Gray Zone Lymphomas: Burkitt-like / DLBCL. 3rd National Lymphoma and Myeloma Congress, Antalya, May 2012

Management of gastrointestinal lymphomas. 2nd International Gastrointestinal Cancer Conference, Istanbul, Turkey, December 2012

Treatment of Aggressive B-Cell Lymphomas. 20th National Cancer Congress, Antalya, April 2013

Leukemia and Lymphomas. 8th National Cancer Patients Congress, Ankara, April 2013

Management of gastrointestinal lymphomas. 3rd International Gastrointestinal Cancer Conference, Antalya, Turkey, December 2013

National Stem Cell Policies Workshop. Kayseri, December 2013

Hematological Malignancies: T-Cell Lymphoma. 5th Turkish Medical Oncology Congress, Antalya, March 2014

Oncology Pharmacy as a Physician. National Hospital Pharmacists Congress, TRNC, April 2014

Overview of Cancer and Stem Cell Transplantation. 15th Congress of Advances in Physiotherapy, Ankara, April 2014

Leukemia and Lymphomas. 9th National Cancer Patients Congress, Ankara, April 2014
Identification of TKI resistance in Leukemia and Lymphoma enables the development of new drugs. Target Cancer 2014, TRNC, April 2014

Treatment Alternatives in Relapsed Hodgkin Lymphoma After Autologous Stem Cell Transplantation. 9th National Apheresis Congress, TRNC, September 2014
 
Treatment of Hodgkin Lymphoma and CD30+ Anaplastic Large Cell Lymphoma in Geriatrics. 3. National Geriatric Hematology Congress, Ankara, September 2014

Hodgkin Lymphoma: Diagnosis and Staging. V. International Eurasian Hematology Congress, Antalya, Turkey, October 2014

Management of gastrointestinal lymphomas. 4th International Gastrointestinal Cancer Conference, Istanbul, Turkey, December 2014

Hematopoietic Stem Cell Transplantation in Peripheral T-cell Lymphomas. II. Hematological Oncology and Bone Marrow Transplantation Symposium, TRNC, February 2015

Current Treatment in CD30+ Lymphomas. II. International Congress of Experimental Hematology, Kayseri, April 2015

Leukemia and Lymphomas. 10. National Cancer Patients Congress, Ankara, April 2015

Treatments in transplant candidate multiple myeloma patients. Turkish Society of Medical Oncology-Hematological Malignancies Course, Adana, November 2015

Treatments and maintenance therapy in multiple myeloma patients who are not transplant candidates. Turkish Society of Medical Oncology-Hematological Malignancies Course, Adana, November 2015
Treatments in transplant candidate multiple myeloma patients. 3rd Hematological Oncology and Bone Marrow Transplant Symposium, TRNC, February 2016

Hematopoietic stem cell transplantation in extranodal lymphomas. 3rd Hematological Oncology and Bone Marrow Transplant Symposium, TRNC, February 2016
 
New therapies in hematological tumors: Myeloma and Leukemias. 6th Turkish Medical Oncology Congress, Antalya, March 2016

Leukemia and Lymphomas. 11th National Cancer Patients Congress, Ankara, April 2016

Aggressive B Cell Lymphomas. European Association of Haematopathology (EAHP) & International Academy of Pathology (IAP) Turkish Division: Lymphoma Course “Updates in WHO Lymphoma Classification: 2008-2016” Practical Diagnostic Approach with Clinical Aspects, Istanbul, Turkey, April 2016.

National Meeting and Congress Proceedings:
Koca G, Sayla F, Konar NM, Özdemir E. The Effect of Body Mass Index on Autologous Hematopoietic Stem Cell Mobilization. Poster Presentation, 11th National Apheresis Congress, Istanbul, 3-6 November 2016. Congress Proceedings P1, 2016.
Işık N, Altan S, Erbiyik E, Topçu P, Alpaslan F, Özdemir E. Frequency of Hypocalcemia and Reasons Affecting the Development of Hypocalcemia During Platelet Apheresis. Poster Presentation, 11th National Apheresis Congress, Istanbul, 3-6 November 2016. Congress Proceedings P8, 2016.
Alpaslan F, Topçu P, Altan S, Işık N, Erbıyık E, Koca G, Özdemir E. The relationship between marital status and educational status of the rate of infectious diseases seen in donors who applied to Hacettepe University Oncology Hospital Apheresis Unit to give platelets. Poster Presentation, 10th National Apheresis Congress, Istanbul, 5-8 November 2015. Congress Proceedings P35, 2015.
Sunar V, Yaşar A, Sarıcı SF, Esin E, Diker Ö, Laçin Ş, Türker A, Özdemir E, Barışta İ, Kars A. Retrospective evaluation of primary central nervous system lymphomas, single center experience. Poster Presentation, 21st National Cancer Congress, Antalya, 22-26 April 2015. Congress Proceedings P:541, 2015.
Sarıcı F, Kertmen N, Aslan AC, Taşdemir V, Babacan T, Kılıçkap S, Özdemir E, Barışta İ, Türker A, Kars A. Anthracycline use in lymphoma patients over the age of 75. Poster Presentation, 21st National Cancer Congress, Antalya, 22-26 April 2015. Congress Proceedings P:499, 2015.
Şener YZ, Akın S, Diker Ö, Topel Ç, Kertmen N, Özdemir E. A case of multiple myeloma presenting with ptosis and pituitary insufficiency, and pituitary functions recovered after autologous bone marrow transplantation. Poster Presentation, 21st National Cancer Congress, Antalya, 22-26 April 2015. Congress Proceedings P:362, 2015.
Akın S, Bayrak A, Gültekin M, Karakaş Y, Özdemir E. Atypical mantle cell lymphoma recurrence in the thigh treated with radiotherapy. Poster Presentation, 21st National Cancer Congress, Antalya, 22-26 April 2015. Congress Proceedings P:360, 2015.
Solak M, Kılıçkap S, Aksoy S, Erman M, Özdemir E, Altundağ MK, Türker A, Yalçın S, Barışta İ, Güllü Hİ, Özışık Y, Kars A, Çelik İ. Single Center Experience in Skin Malignant Melanoma. Poster Presentation, 5th Turkish Medical Oncology Congress, Antalya, 19-23 March 2014. Congress Proceedings P:372, 2014.
Kertmen N, Erman M, Özdemir, E. Chronic myelocytic leukemia (CML) developing after radioactive iodine therapy (RAI) given in the course of thyroid cancer. Poster Presentation, 20th National Cancer Congress, Antalya, 19-23 April 2013. Congress Proceedings P:291, 2013.
Arslan Ç, Özdemir E, Barışta İ, Kars A, Türker A, Kansu E. Efficacy and Toxicity Evaluation of Ifosfamide, Idarubicin, Etoposide (IIVP) Regime in Patients with Relapsed-Refractory Hodgkin Lymphoma. Oral Presentation, 4th Medical Oncology Congress, Antalya, 21-25 March 2012. Congress Proceedings P:129, 2012.
Büyükaşık Y, Acar K, Kelkitli E, Şerefhanoğlu S, Özdemir E, Uz B, Atay H, Pamukçuoğlu M, Bektaş Ö, Sucak GT, Turgut M, Özcebe O. Hyper-CVAD protocol and other intensive therapy in the treatment of adult acute lymphoblastic leukemia. Comparison of regimens: A multicenter retrospective study. Oral Presentation, 37. National Hematology Congress, Ankara, 19-22 October 2011. Congress Proceedings P:8-9, 2011.
Arslan Ç, Özdemir E, Barışta İ, Türker A, Kars A, Özışık Y, Kansu E. Efficacy and toxicity evaluation of ICE and IIVP rescue chemotherapy regimens in patients with relapsed/refractory Hodgkin lymphoma. Oral Presentation, XIX. National Cancer Congress, Antalya, 20-24 April 2011. Congress Proceedings P:28, 2011.
Petekkaya I, Topçuoğlu MA, Gezgen G, Roach EC, Özdemir E, Altundağ K. Chemotherapy-associated periodic paralysis: hypokalemia mimicking a cerebrovascular event. VIII. National Medical Oncology Congress, Dalaman, Muğla, 14-18 September 2011. Congress Proceedings P:266, 2011.
Doğan E, Gököz Ö, Özdemir E. Thalidomide-induced leukocytoclastic vasculitis in multiple myeloma: two case reports. Poster Presentation, XIX. National Cancer Congress, Antalya, 20-24 April 2011. Congress Proceedings P: 314, 2011.
Arslan Ç, Özdemir E, Doğan E, Özışık Y, Altundağ K. Secondary hematological malignancies developing during early stage breast cancer. Poster Presentation, XIX. National Cancer Congress, Antalya, 20-24 April 2011. Congress Proceedings P: 411, 2011.
Arslan Ç, Özdemir E, Kars A, Türker A, Barışta İ, Özışık Y, Altundağ K. Promyelocytic leukemia developing during the course of breast cancer: 3 cases. Poster Presentation, XIX. National Cancer Congress, Antalya, 20-24 April 2011. Congress Proceedings P:615 2011.
Şerefhanoğlu S, Büyükaşık Y, Göker H, Turgut M, Aslan R, Özdemir E, Sayınalp N, Haznedaroğlu IC, Aksu S, Özcebe Oİ. Clinical features and treatment outcomes of 49 newly diagnosed acute promyelocytic leukemia patients treated with the Pethema protocol. Oral Presentation, 36. National Hematology Congress, Antalya 3-7 November 2010. Congress Proceedings P:6, 2010.Arslan Ç, Özdemir E, Aksoy S, Dede D, Doğan E, Özışık Y, Altundağ K. Meme kanseri ile birlikte görülen hematolojik maligniteler: tek merkez deneyimi. Poster Sunumu. 17. Ulusal Cerrahi Kongresi, Ankara, 26-29 Mayıs 2010. Poster No: 888.
Arık Z, Özkan Ç, Özdemir E, Altundağ K. Her-2 positive breast cancer that emerged four years later in a patient followed up with the diagnosis of Agnogenic Myeloid Metaplasia. Poster Presentation III. Medical Oncology Congress, Antalya, 24-28 March 2010. Congress Proceedings P:48, 2010.
Kara Ö, Özdemir E, Arslan Ç, Doğan E, Altundağ K. Acute promyelocytic leukemia developing three years after breast cancer diagnosis. Poster Presentation III. Medical Oncology Congress, Antalya, 24-28 March 2010. Congress Proceedings P:57-58, 2010.
Kalpakçı Y, Özdemir E, Sarıcı F, Aksoy S, Arslan Ç, Dede D, Doğan E, Altundağ K. Coexistence of breast cancer and idiopathic thrombocytopenic purpura: case report, review of the literature. Poster Presentation III. Medical Oncology Congress, Antalya, 24-28 March 2010. Congress Proceedings P:72-73, 2010.
Büyükaşık Y, Sayınalp N, Özdemir E, Şerefhanoğlu S, Aksu S, Göker H, Haznedaroğlu İ, Özcebe Oİ. Retrospective evaluation of fludarabine, cyclophosphamide and rituximab (FC-R) chemotherapy in patients with newly diagnosed and relapsed/refractory chronic lymphocytic leukemia. Oral Presentation, 35th National Hematology Congress, Antalya 7-10 October 2009. Congress Proceedings P:54, 2009.
Göker H, Şerefhanoğlu S, Özdemir E, Aksu S, Büyükaşık Y, Sayınalp N, Haznedaroğlu IC, Turgut M, Karacan Y, Özcebe Oİ. Hematopoietic stem cell transplantation in adult patients with acute leukemia: Hacettepe University Hematology-Medical Oncology Experience 2001-2009. Oral Presentation, 35th National Hematology Congress, Antalya 7-10 October 2009. Congress Proceedings P:62-63, 2009.
Altan S, Duran Y, Topçu P, Özdemir E. Complications during stem cell apheresis and thrombophoresis procedures. Poster Presentation, 4th National Hemapheresis Congress, TRNC, 24-27 September 2009. Congress Proceedings P:215-216, 2009.
Ağbaba SK, Emre S, Özdemir E, Demir Ç, Kutluk T. Monitoring minimal residual disease in patients with Chronic Myeloid Leukemia. Poster Presentation, XVIII. National Cancer Congress, Antalya, 21-26 April 2009. Congress Proceedings P:195-196, 2009.
Arpacı F, Öztürk M, Özdemir E, Abstract A, Ataergin S, Dağdaş S, Kuzhan O, Kılıç S, Öztürk B, Kömürcü Ş, Abstract G. High-dose chemotherapy and autologous peripheral blood stem stem cell tumors in relapsed/refractory testicular germ cell tumors cell transplantation: Turkish Oncology Group study. Oral Presentation, XVIII. National Cancer Congress, Antalya, 21-26 April 2009. Congress Proceedings P:6, 2009.Aydin K, Özdemir E, Işıldak M, Bayraktar M. Three cases of multiple myeloma with thyroid involvement. Poster Presentation, 3rd Turkish Thyroid Diseases Congress, Trabzon, 17-20 April 2008. Congress Proceedings P:21, 2008.
Ozmen F, Ozmen MM, Moran M, Ozdemir E, Seçkin S, Guc D, Kansu E. Can LYVE-1, VEGFR-3, CD44 gene expressions be a leading indicator for lymphatic metastasis in gastric cancers? Oral Presentation, 2nd Medical Oncology Congress, Antalya, 26-30 March 2008. Congress Proceedings P:58, 2008.
Aksoy S, Koçal N, Akdoğan S, Özdemir E, Kansu E. Alternative therapy usage habits in patients undergoing stem cell transplantation. Poster Presentation, 2nd Medical Oncology Congress, Antalya, 26-30 March 2008. Congress Proceedings P:134, 2008.
Yüce S, Özdemir E, Oyan B, Koç Y. High survival rate achieved by autologous or allogeneic stem cell transplantation after high-dose sequential chemotherapy in advanced Burkitt and lymphoblastic lymphoma patients (LL-2001 protocol). Poster Presentation, 5th National Bone Marrow Transplantation and Stem Cell Therapy Congress, Antalya, 6-9 March 2008. Congress Proceedings P:210-211, 2008.
Oyan B, Özdemir E, Koç Y. High complete remission and survival rates achieved by rational application of sequential autologous/allogeneic transplantation and thalidomide/bortezomib maintenance treatments in the treatment of myeloma. Oral Presentation, Turkish Society of Hematology XXXIII. National Congress, Ankara, 16-19 October 2007. Turkish Journal of Haematology, Suppl. 1 Vol:24(4), 70, 2007.
Aksoy S, Koçal N, Akdoğan S, Özdemir E, Kansu E. Alternative therapy usage habits in patients undergoing stem cell transplantation. Oral Presentation, Turkish Society of Hematology XXXIII. National Congress, Ankara, 16-19 October 2007. Turkish Journal of Haematology, Suppl. 1 Vol:24(4), 76-77, 2007.
Kıratlı PÖ, Özdemir E, Barışta İ, Özcebe O, Uğur Ö. Radioimmunotherapy with Yttrium-90 ibritumomab tiuxetan in non-Hodgkin's lymphoma. Oral Presentation, XVII. National Cancer Congress, Antalya, 19-23 April 2007. Congress Proceedings P:120, 2007.
Akgedik K, Zengin H, Akdoğan S, Gündoğdu F, Özdemir E. Permanent central venous implanted port catheter maintenance frequency and complication status- Hacettepe University Oncology Institute KIT Day Treatment Unit Experience. Oral Presentation, Turkish Society of Hematology XXXII. National Congress, Antalya, 8-12 November 2006. Turkish Journal of Haematology, Suppl. 1 Vol:23(3), 39-40, 2006.
Özdemir E, Koç Y, Kars A, Türker A, Tekuzman G, Kansu E. The efficacy of bortezomib, thalidomide and dexamethasone (VTD) combination therapy in relapsed/refractory multiple myeloma. Oral Presentation, Turkish Society of Hematology XXXII. National Congress, Antalya, 8-12 November 2006. Turkish Journal of Haematology, Suppl. 1 Vol:23(3), 83, 2006.
Akdoğan S, Akgedik K, Gündoğdu F, Özdemir E. Sexual problems after stem cell transplantation. Oral Presentation, Turkish Society of Hematology XXXII. National Congress, Antalya, 8-12 November 2006. Turkish Journal of Haematology, Suppl. 1 Vol:23(3), 86, 2006.
Akgedik K, Akdoğan S, Gündoğdu F, Özdemir E. Side effects during frozen autologous stem cell infusion: Hacettepe University Oncology Institute Stem Cell Transplantation Unit Experience. Poster Presentation, Turkish Society of Hematology XXXII. National Congress, Antalya, 8-12 November 2006. Turkish Journal of Haematology, Suppl. 1 Vol:23(3), 192-193, 2006.
Özdemir E, Koç Y, Oyan B, Kansu E. Non-myeloablative allogeneic stem cell transplantation (NST): Experience of Hacettepe Oncology Institute. Oral Presentation, Turkish Society of Hematology XXXI. National Congress, Antalya, 23-28 September 2004. Turkish Journal of Haematology, Suppl. Vol:21(3), 39, 2004.
Oyan B, Koç Y, Özdemir E, Kars a, Türker A, Tekuzman G, Kansu E. Autologous stem cell transplantation (SCN) in multiple myeloma, nonmyeloablative allogeneic stem cell transplantation (NST), rational use of thalidomide and Bortezomib achieving remission. Oral Presentation, Turkish Society of Hematology XXXI. National Congress, Antalya, 23-28 September 2004. Turkish Journal of Haematology, Suppl. Vol:21(3), 64, 2004.
Oyan B, Koç Y, Özdemir E, Kansu E. High-dose sequential chemotherapy (YDAC) accompanied by autologous stem cell transplantation (OSC) in patients with relapsed/refractory Hodgkin's lymphoma and Non-Hodgkin's lymphoma (NHL). Poster Presentation, Turkish Society of Hematology XXXI. National Congress, Antalya, 23-28 September 2004. Turkish Journal of Haematology, Suppl. Vol:21(3), 150, 2004.Oyan B, Koç Y, Kars A, Barışta İ, Türker A, Abalı H, Özdemir E, Tekuzman G, Kansu E. Relaps/Refrakter hodgkin’s lenfoma (HL) ve Non-Hodgkin’s lenfoma (NHL)’da kurtarma tedavisi olarak IIVP rejimi ile yüksek cevap oranları.  Sözel Sunum, Türk Hematoloji Derneği XXXI. Ulusal Kongresi, Antalya, 23-28 Eylül 2004. Turkish Journal of Haematology, Suppl. Vol:21(3), 43, 2004.
Cirit M, Özdemir E, Akçiçek F, Ok E, Soydaş C, Mees EJD. Doppler echocardiographic findings in hypervolemic hemodialysis patients. XII. National Nephrology Congress, Abant, Abstract Book, p. 102, October 3-7, 1995.
Cirit M, Ok E, Özdemir E, Saydam G, Akçiçek F, Atabay G, Başçı A. A retrospective review of permanent internal jugular catheterization in hemodialysis patients. XII. National Nephrology Congress, Abant, Abstract Book, p. 96, 3-7 October 1995.
Cirit M, Çağırgan S, Ok E, Saydam G, Özdemir E, Önder G, Tombuloğlu M, Başçı A. IgA nephropathy presenting with acute renal failure during the course of ALL in remission. XII. National Nephrology Congress, Abant, Abstract Book, p. 201, 3-7 October 1995.
Cirit M, Arkun R, Özbek S, Töbü M, Saydam G, Özdemir E, Başçı A. Percutaneous fine needle ethanol injection in secondary hyperparathyroidism. XII. National Nephrology Congress, Abant, Abstract Book, p. 160, 3-7 October 1995.
Töbü M, Karabulut B, Özkahya M, Ok E, Saydam G, Özdemir E, Akçiçek F, Atabay G. Clinical course in 16 cases of crescentic glomerulonephritis. XI. National Nephrology Congress, Samsun, Abstract Book, p. 187, 11-14 October 1994.
Cirit M, Ok E, Kürşat S, Saydam G, Özdemir E, Tokat Y, Atabay G. Acute tubular necrosis after cyclosporine in a renal transplant patient. XI. National Nephrology Congress, Samsun, Abstract Book, p. 184, 11-14 October 1994.
Cirit M, Keskin A, Karaca E, Tombuloğlu M, Özkahya M, Özdemir E, Başçı A, Büyükkeçeci F. Comparison of low molecular weight heparin (fraxiparin) and standard heparin in hemodialysis. XI. National Nephrology Congress, Samsun, Abstract Book, p. 183, 11-14 October 1994.
Cirit M, Soydaş C, Terzioğlu E, Özdemir E, Akçiçek F, Atabay G. The reason for the paradoxical increase in blood pressure during ultrafiltration in hemodialysis patients. X. National Nephrology Congress, Bursa, Abstract Book, p. 31, 19-22 October 1993.
Ok E, Özdemir E, Tokat Y, Hoşcoşkun C, Töbü M, Karaca E, Akçiçek F, Başçı A. Hepatic indicators in renal transplant recipients; A retrospective study to elucidate etiological indicators. X. National Nephrology Congress, Bursa, Abstract Book, p. 38, 19-22 October 1993.
Özdemir E, Ok E, Kürşat S, Cirit M, Başak K, Töz H, Akalın E, Atabay G. Hepatic indicators in chronic adult hemodialysis patients; retrospective study examining etiological relationships. X. National Nephrology Congress, Bursa, Abstract Book, p. 177, 19-22 October 1993.

International Meeting and Congress Papers:

Aslan A, Turker A, Kars A, Barista I, Özdemir E. Rituximab in Combination with Cyclophosphamide, Mitoxantrone, Vincristine and Prednisone (R-CNOP) As First Line Regimen in Elderly Patients with Diffuse Large B-Cell Lymphoma Blood 128:5390, 2016.
Aslan T, Özdemir E, Uner A, Gungor E, Aslan NA, Yildizhan E, Agit A, Korkmaz S, Cagliyan GA, Barista I, Ozhamam E, Pamuk GE, Turgut M, Eser B, Ozet G, Yıldırım R, Buyukasik Y. Splenic Marginal Zone Lymphoma in an East Mediterranean/Middle Eastern Population Cohort: Possible Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Prognostic Factor (ThREG-NHL01 Study). Blood 128:5332, 2016.
Bahcecioglu AB, Etgul S, Aslan T, Aydın MS, Malkan UY, Okay M, Özdemir E, Ciftciler R, Goker H, Buyukasik Y. Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms. Blood 128:5483, 2016.
Özdemir E, Aslan A, Turker A, Barısta I, Kars A. Gemcitabine in combination with oxaliplatin (GemOx) as a salvage regimen in patients with relapsed/refractory Hodgkin’s lymphoma. Poster Presentation 57th ASH Annual Meeting, December 5-7, 2015. Blood 126 (23):1517, 2015.
Özdemir E, Aslan A, Turker A, Barısta I, Kars A. Single agent gemcitabine as a salvage regimen in patients with relapsed/refractory Hodgkin’s lymphoma after autologous stem cell transplantation. Blood 126 (23):5090, 2015.
Özdemir E, Akın S. Atypical recurrence of mantle cell lymphoma three years after autologous stem cell transplantation mimicking soft tissue sarcoma. Poster Presentation, Poster No:18, Lymphoma and Myeloma 2015: An International Congress on Hematologic Malignancies, New York, NY, 22-24 October 2015. 
Tuglular ATF, Pehlivan M, Sari HI, Ayyildiz MO, Saydam G, Sonmez M, Besisik SK, Ozgur G, Gurkan E, Kaynar L, Ali R, Ozet G, Demirkan F, Ongoren S, Ozdogu H, Gunduz E, Tiftik EN, Salim O, Turgut M, Hacihanefioglu A, Ure UB, Özdemir E, Altuntas F, Simsek D, Ulu N, Beksac M. Post-authorization safety of lenelidomide + dexamethasone in patients with relapsed/refractory multiple myeloma: early safety report of Turkish PASS Study. Haematologica 100 (s1): 734, 2015 (Abstract Book 20th Congress of the European Hematology Association, Vienna, June 2015)
Sunar V, Yasar A, Sarici F, Esin E, Diker O, Lacin S, Turker A, Özdemir E, Barısta I, Kars A. A retrospective analysis of central nervous system lymphomas: single center experience. J Clin Oncol 33, 2015 (suppl; abstr e13053)
Tekgunduz, A. I. E., Kaya, A. H., Goker, H., Özdemir, E., Iskender, D., Kocubaba, S., Koyikci, O., Altuntas, F. Biosimilar filgrastim (Leucostim (R)) seems to have similar efficacy in hematopoietic progenitor cell mobilization compared to original filgrastim (Neupogen (R)) and lenograstim (Granocyte (R)): a retrospective, multicenter analysis. Bone Marrow Transplantation Volume: 50, Pages: S338-S338, Supplement: 1, Meeting Abstract: P429, MAR 2015 
Goker H, Eliacik E, Altuntas F, Tekgunduz E, Özdemir E, Isik A, Kayikci O, Kaya AH, Aksu S, Haznedaroglu IC, Sayinalp N, Demiroglu H, Ozcebe OI, Buyukasik Y. Lower doses of Plerixafor use is sufficient to effectively mobilize PBSC (peripheral blood hematopoietic stem cells) when compared to standart administration. Blood, 124(21), 5830, Dec 6, 2014.
Özdemir, E. Hodgkin’s Lymphoma: Diagnosis and Staging. Leukemia Research Volume: 38, Pages: S4-S4, Supplement: 1, Meeting Abstract: SP-010, OCT 2014 
Özdemir E. Nasal type natural killer/T cell lymphoma during the course of Behçet's Disease: A case report. Poster Presentation, Poster No:30, Lymphoma and Myeloma 2014: An International Congress on Hematologic Malignancies, New York, NY, 23-25 October 2014. 
Ferhanoglu B, Salihoglu A, Elverdi T, Karadogan I, Özdemir E, Erdem G, Karadurmus N, Akyol G, Kaynar L, Yegin A, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E, Goker H, Baslar Z, Paydas S. Brentuximab Vedotin for relapsed or refractory Hodgkin’s Lymphoma: Experience in Turkey. Haematologica 99 (s1): 675-676, 2014 (Abstract Book 19th Congress of the European Hematology Association, Milan, June 2014)
Özdemir E, Doğan E, Gököz Ö. Thalidomide related leukocytoclastic vasculitis in two patients with multiple myeloma. Poster Presentation, Poster No:8, Lymphoma and Myeloma 2013: An International Congress on Hematologic Malignancies, New York, NY, 24-26 October 2013. 
Ozturk M, Arpaci F, Ozaydın S, Karadurmus N, Özdemir E, Ataergin S, Erdem G, karaca H, Cakar M, Turker T, Ozet A, Kuzhan O, Kilic S, Komurcu S, Ozet G, Dagdas S, Ozturk B, Sivgin S. High-dose chemotherapy and autologous stem cell transplantation in refractory/metastatic nonseminomatous germ cell-tumors: A retrospective study of the Turkish Oncology Association. J Clin Oncol 31, 2013 (suppl; abstr e 15623)
Goker H, Özdemir E, Uz B, Buyukasik Y, Turgut M, Serefhanoglu S, Aksu S, Sayinalp N, Haznedaroglu IC, Tekin F, Unal S, Bektas O, Eliacik E, Isik A, Ozcebe OI. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for acute leukemia patients: a single center experience. Bone Marrow Transplantation 48: Issue S2:S537, April 2013.
Özdemir E, Atasever T. Detection of multiple extramedullary plasmacytomas of upper airways by F-18 FDG PET/CT imaging. Poster Presentation, 14th International Myeloma Workshop, Kyoto, Japan, April 3-7, 2013. Clinical Lymphoma, Myeloma and Leukemia Vol 13, Suppl 1 pp. A1-A10, S132, April 2013 (Abstract Book 14th International Myeloma Workshop)
Arslan C, Özdemir E, Barısta I, Turker A, Kars A, Ozısık Y, Kansu E. Efficacy and toxicity fof ICE (ifosphamide, carboplatin, and etoposide) IIVP (ifosphamide, idarubicin, and etoposide) salvage chemotherapy regimens in relapse/refractory Hodgkin lenfoma patients. J Clin Oncol 29, 2011 (suppl; abstr e 18563)
Arslan C, Özdemir E, Dogan E, Ozisik Y, Altundag K. Secondary hematological malignancies after treatment of non-metastatic breast cancer. Haematologica 96 (s2):259, 2011 (Abstract Book 16th Congress of the European Hematology Association, London, June 2011)
Arpaci F, Ozturk M, Özdemir E, Ozet A, Ataergin S, Dagdas S, Kuzhan O, Kilic S, Ozturk B, Komurcu S, Ozet G. Salvage high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with relapsed or refractory germ cell tumors: a Turkish Oncology Group Study. Poster Presentation, 35th Annual Meeting of the EBMT, Goteburg, Sweden, March 29-April 1, 2009. Bone Marrow Transplantation 43 (suppl 1), p:155-156, March 2009.
Aksoy S, Kocal N, Akdogan S, Özdemir E. The prevalence and determinants of the use of complementary and alternative medicine in hematopoietic stem cell transplantation patients. Poster Presentation, BMT Tandem Meetings CIBMTR/ASBMT, San Diego, CA, February 13-18, 2008. Biology of Blood and Marrow Transplantation 14 (2) Suppl 2, Abstract No: 261, p:96-97, February 2008.
Akgedik A, Akdogan S, Aksoy S, Özdemir E. The popsickle with strawberry aroma reduces infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells. Poster Presentation, BMT Tandem Meetings CIBMTR/ASBMT, San Diego, CA, February 13-18, 2008. Biology of Blood and Marrow Transplantation 14 (2) Suppl 2, Abstract No: 264, p:97-98, February 2008.
Özdemir E, Koç Y, Kars A, Türker A, Tekuzman G, Kansu E. Bortezomib, dexamethasone and concomitant or sequential thalidomide (VTD): An effective combination for relapsed/refractory multiple myeloma failing thalidomide and dexamethasone. Blood 110(11):276B 4810 Part 2 Nov 16, 2007.
Kıratlı P, Erbaş B, Özdemir E, Koç Y. Is there a predictive role for GA-67 scintigraphy in patients with lymphoma undergoing autologous stem cell transplantation? Haematologica-The Hematology Journal, 92:480-480 1332 Suppl. 1 Jun 2007.
Komanduri KV, John LSS, Shpall EJ, Champlin RE, Molldrem JJ, Özdemir E. CMV reactivation after allogeneic stem cell transplantation is associated with a preponderance of circulating late-stage CMV-specific CD8+ T cells.  Poster Presentation, 47th Annual Meeting of American Society of Hematology, Atlanta, GA. Blood, 106, 3250, Part 1, Nov 16 2005.   
Kiratli PO, Koc Y, Erbas B, Özdemir E. Predictive value of Ga-67 scintigraphy in patients with lymphoma undergoing autologous stem cell transplantation.  European Journal of Nuclear Medicine and Molecular Imaging, 32, 26, September 2005.
Oyan B, Koc Y, Özdemir E, Kansu E. High-dose sequential chemotherapy coupled with autologous PBSCT and in vivo purging with rituximab in patients with relapsed/refractory or high-risk B-cell NHL.  Bone Marrow Transplantation, 35, 385, March 2005.
Koc Y, Özdemir E, Oyan B, Kansu E. Nonmyeloablative Allogeneic Stem Cell Transplantation: Hacettepe University Institute of Oncology Experience.  Blood, 104, 5155, Part 2, Nov 16 2004.  
Oyan B, Koc Y, Özdemir E, Kansu E. High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin’s lymphoma (HL) and Non-Hodgkin’s lymphoma (NHL). Blood, 104, 5231, Part 2, Nov 16 2004. 
Özdemir E, Saliba R, Champlin RE, Komanduri KV. A model to predict risk for late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematologic malignancies.  Poster Presentation, 46th Annual Meeting of American Society of Hematology, San Diego, CA. Blood, 104, 2241, Part 1, Nov 16 2004.
Komanduri KV, Özdemir E, Gillespie G, St.John LS, Rowland-Jones S, Champlin RE, Molldrem JJ. Definitive evidence for an immunodominance hierarchy in the human CD8+ T cell response to Cytomegalovirus.  Blood, 100, 5209, Part 2, Nov 16 2002.
Özdemir E, St.John LS, Champlin RE, Molldrem JJ, Komanduri KV.  Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with impaired cytomegalovirus-specific CD8+ T cell function.  Poster Presentation. Trainee Recognition Day, MD Anderson Cancer Center, Houston, TX, May 8-10 2002.
Özdemir E, St.John LS, Champlin RE, Molldrem JJ, Komanduri KV. Characterization of Immunodominance Hierarchies in the CD8+ T cell response to the Cytomegalovirus pp65 matrix protein. Poster Presentation. Trainee Recognition Day, MD Anderson Cancer Center, Houston, TX, May 8-10 2002 
Özdemir E, St.John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ, Komanduri KV. Cytomegalovirus-specific CD8+ T cell recovery, as measured by HLA-peptide tetramer staining, is insufficient to control viremia following allogeneic stem cell transplantation.  Poster Presentation, 43rd Annual Meeting of American Society of Hematology, Orlando, FL. Blood, 98, 1638, Part 1, Nov 16 2001. 
Özdemir E, Basu S, Winkelmann JC. HAR, a CD44 homolog, binds hyaluronic acid and has a highly conserved murine counterpart, mHAR. Blood, 94, 3921, Part 2, Suppl. 1, Nov 15 1999.
Cirit M, Soydaş C, Özdemir E, Ok E, Kürşat S, Ünsal A, Mees EJ Dorhout. Functional valvular regurgitation in hemodialysis (HD) patients. XXXIIIrd Congress of the European Renal Association European Dialysis and Transplant Association, Amsterdam, The Netherlands, Abstract Book, page 87, June 18-21 1996. 
Özdemir E, Ok E, Kürşat S, Cirit C, Başak K, Töz H, Akalın E, Atabay G. Hepatic markers of chronic adult hemodialysis patients-a retrospective study investigating etiologic correlation. Kidney International, 48, 1680-1681, 1995.
Dönmez A, Çal C, Özdemir E, Özyurt C, Hekimgil M, Çağırgan S, Çıkılı N, Büyükkeçeci F, Soydan S. Prostatic Involvement of Non-Hodgkin’s Lymphoma.  XIIIth Meeting of the International Society of Hematology, İstanbul, Turkey, Abstract Book, Abst. 886, September 3-8, 1995. 
Şencan M, Çağırgan S, Tombuloğlu M, Dönmez A, Özdemir E, Büyükkeçeci F. Interferon alpha induced rheumatoid arthritis in a patient with hairy cell leukemia. XIIIth Meeting of the International Society of Hematology, İstanbul, Turkey, Abstract Book, Abst. 822, September 3-8, 1995. 
Töbü M, Tombuloğlu M, Çağırgan S, Özdemir E, Atamer M, Büyükkeçeci F. Diabetes insipitus in a case with acute myelogenous leukemia. XIIIth Meeting of the International Society of Hematology, İstanbul, Turkey, Abstract Book, Abst. 835, September 3-8, 1995. 
Çağırgan S, Şencan M, Tombuloğlu M, Özdemir E, Dönmez A, Görgün G, Büyükkeçeci F. An acute megakaryoblastic leukemia case with widespread osteolytic bone lesions. XIIIth Meeting of the International Society of Hematology, İstanbul, Turkey, Abstract Book, Abst. 836, September 3-8, 1995.
Çağırgan S, Şencan M, Tombuloğlu M, Özdemir E, Dönmez A, Görgün G, Büyükkeçeci F. Two consecutive spontaneous regression to chronic phase in a patient with blastic phase chronic myelogenous leukemia. XIIIth Meeting of the International Society of Hematology, İstanbul, Turkey, Abstract Book, Abst. 863, September 3-8, 1995. 
Donmez A, Cal C, Özdemir E, Ozyurt C, Hekimgil M, Cagirgan S, Cikili N, Buyukkececi F, Soydan S: Prostatic Involvement of NonHodgkin Lymphoma. XIIIth Meeting of the International Society of Hematology, Istanbul, Turkey, 1995.
Keser G, Koçanoğulları H, Özdemir E, Kabasakal Y, Tunçbay T, Doğanavşargil E. A case with focal myositis. VII. Mediterranean Congress of Rheumatology, Athens, Greece, Abstract Book, Abst. P48, page 84, June 16-18, 1994.

National Publications:
1. Huri M, Akel BS, Karayazgan S, Özdemir E. Investigation of the effects of neuropsychological functions on quality of life in patients who underwent hematopoietic stem cell transplantation. Journal of Occupational Therapy and Rehabilitation 3(2): 53-58, 2015.
2. Özdemir E. Advances in the diagnosis and treatment of cytomegalovirus infections during allogeneic stem cell transplantation. Hematologist-Bone Marrow Transplantation Special Issue 1(1):90-95, 2011.
3. Özdemir E. Paraneoplastic endocrine syndromes; thyroid hormone disorders, diabetes mellitus and hypoglycemia. Turkiye Klinikleri J Hem Onc-Special Topics 1(3):48-50, 2008.
4. Kıratlı PÖ, Erbaş B, Özdemir E, Koç Y. Ga-67 scintigraphy in lymphoma patients undergoing bone marrow transplantation. Turkish Journal of Cancer 37(2):54-58, 2007.
5. Dizdar Ö, Özdemir E, Üner A, Kansu E. Images in hematology-oncology: A 40-year-old female presenting with a solitary pulmonary nodule. Turkish Journal of Cancer, 36, 35-37, 2006.
6. Özdemir E. Late side effects after Hematopoietic Stem Cell Transplantation. Bone Marrow Transplantation Special Issue Turkiye Klinikleri J Int Med Sci 2(19):83-89, 2006.
7. Özdemir E, Kansu E. Hacettepe University Oncology Institute hematopoietic stem cell transplantation program. Hacettepe Medical Journal, 36, 213-215, 2005.
8. Ozdemir E, Basu S, Blough RI, Winkelmann JC. Description of human and murine CD44 homologs; human HAR (hHAR) and murine HAR (mHAR). Turkish Journal of Cancer, 34, 60-66, 2004.
9. Dönmez A, Çal Ç, Hekimgil M, Çağırgan S, Şencan M, Özdemir E, Özyurt C, Çılılı N, Göker E. Prostatic involvement of non-hodgkin lymphoma: Case report. Medical Journal of Ege University, 7, 41-43, 1997.
10. Göker E, Özdemir E. Tumor markers. Spectrum Reviews, p. 19-27, ed. Kaya Emerk, Açılım Publishing, İzmir, 1997.
11. Cirit M, Arkun R, Özbek S, Sermez Y, Saydam G, Özdemir E, Töbü M, Başçı A. Percutaneous fine needle ethanol injection in two uremic patients with severe secondary hyperparathyroidism. National Journal of Endocrinology, 6, 419-425, 1996.
12. Özdemir E, Sebik F. Etiopathogenesis of bronchial asthma. Academy, 2, 85-103, 1996.
13. Cirit M, Özkahya M, Özdemir E, Başçı A, Atabay G. Purulent pericarditis with cardiac tamponade in two hemodialysis patients. Turkish Journal of Nephrology Dialysis and Transplantation, 5, 40-42, 1996.
14. Saydam G, Cirit M, Özdemir E, Akçiçek F, Atabay G. Metabolic acidosis: a significant catabolic factor in chronic renal failure. SSK Izmir Training Hospital Medical Journal, 1, 39-40, 1995.
15. Özdemir E, Akçiçek F. Immunosuppressive therapy in renal transplantation. Academy, 2, 79-96, 1995.
16. Ok E, Özdemir E, Akçiçek F, Manager N, Töbü M, Cirit M, Atabay G, Batur Y. Changes in the prevalence of HBV and HCV infection in the Hemodialysis Unit. T Klin Gastroenterohepatology, 5, 188-191, 1994.
17. Ok E, Töbü M, Özdemir E, Akçiçek F, Tokat Y, Bor S, Atabay G, Batur Y. HBV, HCV and HDV infections in renal allograft recipients. Gastroenterology, 5, 642-646, 1994.

International Publications

Özdemir E, Turker A, Barısta I, Kars A. The lollipop with strawberry aroma significantly reduces infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells: A randomized study. Submitted to Biol Blood Marrow Transplant, 2020.
Özdemir E, Turker A, Barısta I, Kars A. Gemcitabine in combination with oxaliplatin (GemOx) as a salvage regimen in patients with relapsed/refractory Hodgkin’s lymphoma. Submited to Clinical Lymphoma, Myeloma & Leukemia, 2020.
Özdemir E, Turker A, Barısta I, Kars A. Weekly Paclitaxel and Carboplatin as a salvage regimen in patients with relapsed/refractory Hodgkin’s lymphoma. Submited to Leukemia & Lymphoma, 2020.
Özbalak M, Salihoğlu A, Soysal T, Karadoğan İ, Paydaş S, Özdemir E, Yıldız B, Karadurmuş N, Kaynar L, Yagci M, Özkocaman V, Topçuoğlu P, Özcan M, Birtaş E, Göker H, Ferhanoglu B. Long term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience.  Ann Hematol. 99(2):301-307, 2020.
Okay M, Aslan T, Özdemir E, Uner A, Saglam A, Gungor E, Uysal A, Alayvaz Aslan N, Yildizhan E, Agit A, Dal MS, Korkmaz S, Namdaroglu S, Sivgin S, Akgun Cagliyan G, Demircioglu S, Barista I, Ozhamam E, Vural F, Eser B, Ozet G, Yildirim R, Dogu MH, Berber I, Erkurt MA, Malkan UY, Altuntas F, Buyukasik Y. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor-Multicenter Cohort Study. Turkish Journal of Hematology Oct. 21, 2019.
Aerts-Kaya F, Koca G, Sharafi P, Sayla FC, Akbiyik F, Uckan-Cetinkaya D, Özdemir E. Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+ cell numbers. Bone Marrow Transplant.  53(9):1225-1227, 2018. 
Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Brentuximab Vedotin with Chemotherapy for Stage III and IV Hodgkin’s Lymphoma. N Engl J Med. 378(4):331-344, 2018.
Aslan A, Arat T, Özdemir E. Successful Treatment of Relapsed/Refractory Hodgkin’s Lymphoma with Nivolumab in a Heavily Pretreated Patient with Progressive Disease after Both Autologous and Allogeneic Stem Cell Transplantation. Leuk Lymphoma. 58(3):754-755, 2017. 
Sarici F, Kertmen N, Aslan A, Tasdemir V, Babacan T, Kilickap S, Özdemir E, Barista I, Turker A, Kars A. Antracyclin-Based Chemotherapy in Patients with Non-Hodgkin’s Lymphoma Aged over 75. International Journal of Hematology and Oncology 26(2):1-7, 2016.
Tekgunduz E, Goker H, Kaynar L, Sarı I, Pala C, Dogu MH, Ozturk E, Turgut B, Korkmaz S, Tetik A, Buyukasık Y, Hacıoglu SK, Bozdag SC, Özdemir E, Altuntas F. Adult Philadelphia chromosome-positive acute lymphoblastic leukemia in daily practice: A multicenter experience. Clin Lymphoma Myeloma Leuk. 16(5):269-274, 2016.
Aksu A, Ayyildiz O, Etgul S, Goker H, Gunes G, Haznedaroglu IC, Ilhan O, Kaynar LG, Malkan UY, Özdemir E, Saydam G, Sayinalp N, Sahin F, Turgut M, Unal A. Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders. International Journal of Hematology and Oncology 26(2): 12-19, 2016.
Salihoglu A, Elverdi T, Karadogan I, Paydas S, Özdemir E, Erdem G, Karadurmuş N, Akyol G, Kaynar L, Yegin ZA, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E, Goker H, Baslar Z, Ferhanoglu B. Bretuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. Ann Hematol. 94(3):415-20, 2015.
Bayraktar-Ekincioglu A, Demirkan K, Keskin B, Aslantaş O, Özdemir E. Potential drug interactions and side effects in an outpatient oncology clinic: a retrospective descriptive study. Eur J Hosp Pharm 21:216-221, 2014.
Ayyıldız O, Demirkan F, Goker H, Haznedaroglu IC, Ilhan O, Kaynar LG, Özdemir E, Saydam G, Sayınalp N, Sahin F, Turgut M, Unal A, Vural F. Ibrutinib: From molecule to medicine. International Journal of Hematology and Oncology 3(1):24, 2014. 
Goker H, Özdemir E, Uz B, Buyukasik Y, Turgut M, Serefhanoglu S, Aksu S, Sayinalp N, Haznedaroglu IC, Tekin F, Karacan Y, Unal S, Eliacik E, Isik A, Ozcebe OI. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience. Transfus Apher Sci. August 8, 2013.
Buyukasik Y, Acar K, Kelkitli E, Uz B, Serefhanoglu S, Özdemir E, Pamukcuoglu M, Atay H, Bektas O, Sucak GT, Turgut M, Aksu S, Yagci M, Sayınalp N, Ozcebe OI, Goker H, Haznedaroglu IC. Hyper-CVAD regimen in routine management of adult lymphoblastic leukemia: A retrospective multicenter study. Acta Haematologica 130:199-205, 2013.  
Özdemir E, Kansu E. Deep vein thrombosis following non-myeloablative allogeneic stem cell transplantation: Presentation of three cases and literature review. Turkish Journal of Hematology 30:188-190, 2013.
Camurdanoglu BZ, Esendaglı G, Özdemir E, Canpınar H, Guc D, Kansu E. The effect of granulocyte colony stimulating factor receptor gene missense single nucleotide polymorphisms on peripheral blood stem cell enrichment. Cytokine Nov 15, 2012.
Uz B, Özdemir E, Aksu S, Akyol TK, Jones R. Successful treatment of autoimmune hemolytic anemia with steroid, IVIG, and plasmapheresis in a haploidentical transplant recipient. Turkish Journal of Hematology 29:199-200, 2012. 
Arslan C, Özdemir E, Dogan E, Ozisik Y, Altundag K. Secondary hematological malignancies after treatment of non-metastatic breast cancer. Journal of BUON 16:744-750, 2011.
Ozmen F, Ozmen MM, Özdemir E, Moran M, Seckin S, Guc D, Karaagaoglu E, Kansu E. Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer. World J. Gastroenterol. 17(27):3220-8, 2011.
Kara O, Özdemir E, Arslan C, Dogan E, Altundag K. Acute promyelocytic leukemia in a young patient with breast cancer. Med Oncol. 28(1):249-50, 2011.
Firat F, Ozen G, Yildiz G, Saglam A, Onder S, Tan E, Özdemir E. Late relapse of acute myeloblastic leukemia as myeloid sarcoma causing radiculopathy. Leuk Res. 34(12): e348-350, 2010.
Ararat E, Sahin I, Özdemir E, Altundag K. Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma. Br J Haematol. 151(5):530-531, 2010.
Arik Z, Ozkan C, Özdemir E, Altundag K. Breast cancer in a patient with agnogenic myeloid metaplasia. Souh Med J. 103(10):1075-1076, 2010.
Serefhanoglu S, Buyukasık Y, Goker H, Sayinalp N, Haznedaroglu IC, Aksu S, Ozcebe OI, Turgut M, Aslan R, Özdemir E. Clinical Features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and antracyclines (PETHEMA protocol) therapy. Leuk Res. 34(12): e317-319, 2010.
Özdemir E, Bayraktar M, Sokmensuer C, Kir KM, Kansu E. Late relapse of a light chain myeloma as extramedullary plasmacytoma of the thyroid gland after second allogeneic stem cell transplantation. Clinical Transplantation 23(6): 981-984, 2009.
Oyan B, Koc Y, Özdemir E, Kars A, Turker A, Tekuzman G, Kansu E. High complete remission rate and durable remissions achieved with rational use of autologous stem cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma. Clinical Transplantation 23(6): 839-847, 2009.
Özdemir E, Akgedik K, Akdogan S, Kansu E. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells. Biol Blood Marrow Transplant 14(12):1425-8, 2008.
Özdemir E, Saliba RM, Champlin RE, Couriel DR, Giralt SA, de Lima M, Khouri IF, Hosing C, Kornblau SM, Anderlini P, Shpall EJ, Qazilbash MH, Molldrem JJ, Chemaly RF, Komanduri KV. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Bone Marrow Transplantation 40:125-136, 2007.
Kıratlı PÖ, Erbaş B, Özdemir E, Koç Y. Ga-67 scintigraphy in lymphoma patients undergoing bone marrow transplantation. Turkish Journal of Cancer 37(2):54-58, 2007. 
Dizdar Ö, Özdemir E, Üner A, Kansu E. Images in hematology-oncology: A 40-year-old female presenting with a solitary pulmonary nodule. Turkish Journal of Cancer 36, 35-37, 2006.
Oyan B, Koc Y, Özdemir E, Kars a, Turker A, Tekuzman G, Kansu E. High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma. Leukemia and Lymphoma, 47(8): 1545-1552, 2006.
Özdemir E, Molldrem JJ. Hookworm infection of sigmoid colon masquerading as graft-versus-host disease in an allogeneic stem cell transplant recipient after donor lymphocyte infusion for refractory acute promyelocytic leukemia. Bone Marrow Transplantation, 37, 785-786, 2006.
Özdemir E, Koc Y, Kansu E. Successful treatment of chronic myeloid leukemia with imatinib mesylate in a patient with chronic renal failure on hemodialysis. American Journal of Hematology, 81(6), 474, 2006.  
Oyan B, Koc Y, Özdemir E, Kars A, Turker A, Tekuzman G, Kansu E. Ifosfamide, Idarubicin, and Etoposide in Relapsed/Refractory Hodgkin’s Disease or Non-Hodgkin Lymphoma: A Salvage Regimen with High Response Rates before Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 11, 688-697, 2005.
Özdemir E, Basu S, Blough RI, Winkelmann JC: Description of human and murine CD44 homologs; human HAR (hHAR) and murine HAR (mHAR). Turkish Journal of Cancer, 34(2):60-66, 2004. 
Özdemir E, St. John LS, Molldrem JJ, Gillespie G, Champlin RE, Rowland-Jones S, Komanduri KV. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood, 100, 3690-3697, 2002. 
Çağırgan S, Şencan M, Tombuloğlu M, Özdemir E, Hekimgil M, Büyükkeçeci F. Two Consecutive Spontaneous Regressions to Chronic Phase in a Patient with Blastic Transformation of Chronic Myelogenous Leukemia. Leukemia and Lymphoma, 29, 423-425, 1998.
Kocanogulları H, Özdemir E, Keser G, Tuncbay T, Gumusdis G, Doganavsargil E. Focal Myositis. Clin Rheumatol, 17, 65-67, 1998.
Çağırgan S, Şencan M, Dönmez A, Özdemir E, Tombuloğlu M, Büyükkeçeci F. A case report: Chronic lymphocytic leukemia with widespread osteolytic lesions. Turkish Journal of Haematology, 14, 113-115, 1997. 

Book Section

Özdemir E. Febrile Neutropenia in Aplastic Anemia and Myelodysplastic Syndrome. Chapter 4: Immunocompromised patients in special conditions, Febrile Neutropenia, Editors: Murat Akova, Hamdi Akan, Scientific Medicine Publishing House, 2010, p:321-331.
Özdemir E. Side effects of cancer treatment. Hacettepe University Faculty of Medicine Health Encyclopedia Editor: Prof. Dr. İskender Sayek, Güneş Medical Bookstores, pages: 367-369, 2008.
Özdemir E. Signs and symptoms in cancer. Hacettepe University Faculty of Medicine Health Encyclopedia Editor: Prof. Dr. İskender Sayek, Güneş Medical Bookstores, page: 358, 2008.
Özdemir E. Metastasis. Hacettepe University Faculty of Medicine Health Encyclopedia Editor: Prof. Dr. Iskender Sayek, Gunes Medical Bookstores, pp:447-448, 2008.
Aslan A, Akin S, Babacan T, Özdemir E. Gastrointestinal Lymphomas. Textbook of Gastrointestinal Oncology, Chapter 20, Eds: Philip A. Philip and Suayib Yalcin, Submitted to Springer Publications, 2016.